BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11716224)

  • 1. Concomitant chemoradiation for head and neck cancer: saving lives or grays?
    Henk JM
    Clin Oncol (R Coll Radiol); 2001; 13(5):333-5. PubMed ID: 11716224
    [No Abstract]   [Full Text] [Related]  

  • 2. Cetuximab plus radiotherapy for head and neck cancer.
    Ho AC
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16707760
    [No Abstract]   [Full Text] [Related]  

  • 3. Cetuximab plus radiotherapy for head and neck cancer.
    Cengiz M; Yildiz F; Genc M
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710908
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma.
    Salvajoli JV; Morioka H; Trippe N; Kowalski LP
    Eur Arch Otorhinolaryngol; 1992; 249(4):211-5. PubMed ID: 1642879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Dirix P; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M; Olszewska E; Maksimowicz T
    Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ preservation for advanced head and neck cancer concomitant chemoradiation.
    Brockstein B
    Cancer Treat Res; 2003; 114():235-48. PubMed ID: 12619544
    [No Abstract]   [Full Text] [Related]  

  • 10. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of cancer of the head and neck--a cocktail with your PORT?
    Saunders MI; Rojas AM
    N Engl J Med; 2004 May; 350(19):1997-9. PubMed ID: 15128901
    [No Abstract]   [Full Text] [Related]  

  • 12. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
    Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for squamous cell carcinoma of the head and neck: an overview.
    Espinola TE; White JA
    J La State Med Soc; 1990 Jul; 142(7):15-8. PubMed ID: 2204670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx.
    Loong HH; Winquist E; Waldron J; Chen EX; Kim J; Palma D; Read N; Razak AR; Diaz-Padilla I; Chan K; Bayley A; Hossain M; Wang L; Chin S; Siu LL; Hope A
    Eur J Cancer; 2014 Sep; 50(13):2263-70. PubMed ID: 24953566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous radiochemotherapy in the treatment of inoperable, locally advanced head and neck cancers.
    Awasthy BS; Julka PK; Rath GK; Singh R
    J Assoc Physicians India; 1998 Mar; 46(3):261-2. PubMed ID: 11273342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant methotrexate and radiotherapy in advanced head and neck cancer: 15-year follow-up of a randomized clinical trial.
    Gupta NK; Swindell R
    Clin Oncol (R Coll Radiol); 2001; 13(5):339-44. PubMed ID: 11716226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up on an intensified treatment regimen for advanced resectable head and neck squamous cell carcinomas.
    Grecula JC; Schuller DE; Smith R; Rhoades CA; Nag S; Bauer CJ; Agrawal A; Au JL; Young D; Gahbauer RA
    Cancer Invest; 2001; 19(2):127-36. PubMed ID: 11296617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of distant metastases in head and neck cancer with concomitant chemotherapy.
    Brockstein BE
    J Clin Oncol; 2000 Sep; 18(18):3320-1. PubMed ID: 10986067
    [No Abstract]   [Full Text] [Related]  

  • 20. High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancer.
    Wolff HA; Daldrup B; Jung K; Overbeck T; Hennies S; Matthias C; Hess CF; Roedel RM; Christiansen H
    Radiology; 2011 Mar; 258(3):864-71. PubMed ID: 21339350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.